Alessandro Tavelli

TL;DR: In this article, the authors explored the association between female gender and long COVID syndrome, defined as persistence of physical and/or psychological symptoms for more than 4 weeks after recovery from acute COVID-19 disease.

TL;DR: Investigation of prevalence of anxiety or depression in coronavirus disease 2019 patients at 1 to 3 months from virological clearance by hospital anxiety and depression scale found pathological patients with HADS‐A/D more commonly reported symptom persistence, even after adjustment for age, gender, and disease severity.

TL;DR: This work aimed to estimate the risk of treatment discontinuation and virological failure of DTG‐based regimens from a large cohort of HIV‐infected individuals.

TL;DR: Despite the use of more potent and safer drugs in the last 10 years, and even in a universal health care setting, migrants living with HIV still present barriers to initiating ART and an increased risk of VF compared to natives.

TL;DR: Despite excellent rates of SVR12 rates, only 21% of HIV-HCV co-infected patients are cured, and suboptimal DAA was the only independent predictor of both non-SVR12 and TF.